Douglas Earl Martin — SEC Form 4 filings

SEC reporting owner CIK 1362155. 6 Form 4 filings on record with FilingPulse; latest filed 2026-08-25.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-01-31 to 2026-08-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Allogene Therapeutics, Inc. (ALLO)SVP, General Counsel63 legs · 59,001 sh · $114,2127

Form 4 filings — Douglas Earl Martin

FiledFormIssuerReported transactionsSource
2026-08-254Allogene Therapeutics, Inc. (ALLO)Sale (S): 29,697 @ $2.12EDGAR
2026-02-044Allogene Therapeutics, Inc. (ALLO)Sale (S): 22,900 @ $1.76 · Grant/award (A): 539,072 (derivative) @ $0 · Grant/award (A): 152,480 (derivative) @ $0EDGAR
2025-02-054Allogene Therapeutics, Inc. (ALLO)Sale (S): 6,404 @ $1.71EDGAR
2025-01-284Allogene Therapeutics, Inc. (ALLO)Grant/award (A): 144,928 @ $0 · Grant/award (A): 512,370 (derivative) @ $0EDGAR
2024-08-234Allogene Therapeutics, Inc. (ALLO)Tax withholding (F): 28,310 @ $2.79EDGAR
2024-01-314Allogene Therapeutics, Inc. (ALLO)Grant/award (A): 41,800 @ $0 · Grant/award (A): 147,778 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1362155 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →